Skip to main content

RxNews®

Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.

Avtozma® (tocilizumab-anoh) – New biosimilar approval

January 30, 2025 - Celltrion announced the FDA approval of Avtozma (tocilizumab-anoh), biosimilar to Genentech’s Actemra® (tocilizumab).

Download PDF

Rx navigation